Eisai Co. v. Teva Pharmaceuticals USA, Inc.
180 L. Ed. 2d 818, 131 S. Ct. 2991, 564 U.S. 1001, 2011 U.S. LEXIS 4519, 79 U.S.L.W. 3696
Opinion
On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal [819]*819Circuit with instructions to dismiss the case as moot. See United States v. Munsingwear, Inc., 340 U.S. 36, 71 S. Ct. 104, 95 L. Ed. 36 (1950).
Same case below, 620 F.3d 1341.
Free access — add to your briefcase to read the full text and ask questions with AI
Eisai Co. v. Teva Pharmaceuticals USA, Inc., 180 L. Ed. 2d 818, 131 S. Ct. 2991, 564 U.S. 1001, 2011 U.S. LEXIS 4519, 79 U.S.L.W. 3696 (U.S. 2011).
180 L. Ed. 2d 818 (Eisai Co. v. Teva Pharmaceuticals USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
Azar v. Garza
584 U.S. 726 (Supreme Court, 2018)
Apotex, Inc. v. Daiichi Sankyo, Inc.
781 F.3d 1356 (Federal Circuit, 2015)
Dey Pharma, LP v. SUNOVION PHARMACEUTICALS INC.
677 F.3d 1158 (Federal Circuit, 2012)
Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.
426 F. App'x 904 (Federal Circuit, 2011)